APO Research
Talk to an analyst

APO RESEARCH · REPORT

Avian Influenza Vaccines

Avian influenza refers to the disease caused by infection with avian (bird) influenza (flu) Type A viruses. These viruses occur naturally among wild aquatic birds worldwide and can infect domestic poultry and other bird and animal species. Avian flu viruses do not normally infect humans. However, sporadic human infections with avian flu viruses have occurred.Avian Influenza Vaccines is a kind of vaccine used to prevent infection caused by Avian Influenza bacteria.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Avian influenza refers to the disease caused by infection with avian (bird) influenza (flu) Type A viruses. These viruses occur naturally among wild aquatic birds worldwide and can infect domestic poultry and other bird and animal species. Avian flu viruses do not normally infect humans. However, sporadic human infections with avian flu viruses have occurred.Avian Influenza Vaccines is a kind of vaccine used to prevent infection caused by Avian Influenza bacteria.

Selected research

Industry Growth & Trends

Global Avian Influenza Vaccines Industry Growth and Trends Forecast to 2032

20 December 2025121 pages

Choose your research edition.

Industry ResearchAvian Influenza Vaccines Industry Research Report 2026144 pages · $2,950 USDIndustry Growth & TrendsGlobal Avian Influenza Vaccines Industry Growth and Trends Forecast to 2032121 pages · $3,450 USDMarket StructureGlobal Avian Influenza Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Avian Influenza Vaccines Market Outlook and Growth Opportunities 2026206 pages · $4,250 USDMarket Analysis & ForecastGlobal Avian Influenza Vaccines Market Analysis and Forecast 2026-2032205 pages · $4,950 USD

Market perspective

Avian influenza refers to the disease caused by infection with avian (bird) influenza (flu) Type A viruses. These viruses occur naturally among wild aquatic birds worldwide and can infect domestic poultry and other bird and animal species. Avian flu viruses do not normally infect humans. However, sporadic human infections with avian flu viruses have occurred.Avian Influenza Vaccines is a kind of vaccine used to prevent infection caused by Avian Influenza bacteria.

Global Avian Influenza Vaccines key players include Merial, QYH Biotech, DHN, HVRI, etc. Global top four manufacturers hold a share over 80%.

China is the largest market, with a share about 45%, followed by Asia (Ex.China), and North America, both have a share about 40 percent.

Read the full market overview

In terms of product, Type H5 is the largest segment, with a share over 70%. And in terms of application, the largest application is Chicken, followed by Duck and Goose, etc.

Report Scope

This report provides a structured, data-driven view of the global Avian Influenza Vaccines market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Avian Influenza Vaccines market size, estimates, and forecasts are presented in terms of sales volume (M Doses) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Avian Influenza Vaccines market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Avian Influenza Vaccines.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Avian Influenza Vaccines market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Avian Influenza Vaccines Market by Company

Merial

QYH Biotech

DHN

HVRI

CEVA

Elanco (Lohmann )

Yebio

Zoetis

FATRO

Kyoto Biken

CAVAC

Ringpu Biology

Vaksindo

ChengDu Tecbond

Sindh Poultry Vaccine Centre

Merck Animal Health

Medion

Avimex Animal Health

JOVAC

Bio-Labs

Avian Influenza Vaccines Segment by Type

H5+H7 Avian Influenza Vaccines

H9 Avian Influenza Vaccines

Avian Influenza Vaccines Segment by Application

Chicken Avian Influenza Vaccines

Duck & Goose Avian Influenza Vaccines

Other

Avian Influenza Vaccines Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Avian Influenza Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Avian Influenza Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Avian Influenza Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Avian Influenza Vaccines manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Avian Influenza Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of H5+H7 Avian Influenza Vaccines Table 2. Major Company of H9 Avian Influenza Vaccines Table 3. Global Avian Influenza Vaccines Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Avian Influenza Vaccines Sales by Type (2021-2026) & (M Doses) Table 5. Global Avian Influenza Vaccines Sales Market Share in Volume by Type (2021-2026) Table 6. Global Avian Influenza Vaccines Sales by Type (2021-2026) & (US$ Million) Table 7. Global Avian Influenza Vaccines Sales Market Share in Value by Type (2021-2026) Table 8. Global Avian Influenza Vaccines Price by Type (2021-2026) & (USD/K Doses) Table 9. Global Avian Influenza Vaccines Sales by Type (2027-2032) & (M Doses) Table 10. Global Avian Influenza Vaccines Sales Market Share in Volume by Type (2027-2032) Table 11. Global Avian Influenza Vaccines Sales by Type (2027-2032) & (US$ Million) Table 12. Global Avian Influenza Vaccines Sales Market Share in Value by Type (2027-2032) Table 13. Global Avian Influenza Vaccines Price by Type (2027-2032) & (USD/K Doses) Table 14. North America Avian Influenza Vaccines Sales by Type (2021-2026) & (M Doses) Table 15. North America Avian Influenza Vaccines Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Avian Influenza Vaccines Sales by Type (2021-2026) & (M Doses) Table 17. Europe Avian Influenza Vaccines Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Avian Influenza Vaccines Sales by Type (2021-2026) & (M Doses) Table 19. Asia-Pacific Avian Influenza Vaccines Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Avian Influenza Vaccines Sales by Type (2021-2026) & (M Doses) Table 21. Latin America Avian Influenza Vaccines Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Avian Influenza Vaccines Sales by Type (2021-2026) & (M Doses) Table 23. Middle East and Africa Avian Influenza Vaccines Sales by Type (2021-2026) & (US$ Million) Table 24. Avian Influenza Vaccines Industry Trends Table 25. Avian Influenza Vaccines Industry Drivers Table 26. Avian Influenza Vaccines Industry Opportunities and Challenges Table 27. Avian Influenza Vaccines Industry Restraints Table 28. Global Avian Influenza Vaccines Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Avian Influenza Vaccines Revenue Market Share by Company (2021-2026) Table 30. Global Avian Influenza Vaccines Sales by Company (2021-2026) & (M Doses) Table 31. Global Avian Influenza Vaccines Sales Share by Company (2021-2026) Table 32. Global Avian Influenza Vaccines Market Price by Company (2021-2026) & (USD/K Doses) Table 33. Global Avian Influenza Vaccines Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Avian Influenza Vaccines Major Company Production Sites and Headquarters Table 35. Global Avian Influenza Vaccines Company, Product Type & Application Table 36. Global Avian Influenza Vaccines Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Avian Influenza Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Avian Influenza Vaccines Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Avian Influenza Vaccines Sales by Region (2021-2026) & (M Doses) Table 41. Global Avian Influenza Vaccines Sales Market Share in Volume by Region (2021-2026) Table 42. Global Avian Influenza Vaccines Sales by Region (2021-2026) & (US$ Million) Table 43. Global Avian Influenza Vaccines Sales Market Share in Value by Region (2021-2026) Table 44. Global Avian Influenza Vaccines Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 45. Global Avian Influenza Vaccines Sales by Region (2027-2032) & (M Doses) Table 46. Global Avian Influenza Vaccines Sales Market Share in Volume by Region (2027-2032) Table 47. Global Avian Influenza Vaccines Sales by Region (2027-2032) & (US$ Million) Table 48. Global Avian Influenza Vaccines Sales Market Share in Value by Region (2027-2032) Table 49. Global Avian Influenza Vaccines Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2027-2032) Table 50. Global Avian Influenza Vaccines Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Avian Influenza Vaccines Sales by Application (2021-2026) & (M Doses) Table 52. Global Avian Influenza Vaccines Sales Market Share in Volume by Application (2021-2026) Table 53. Global Avian Influenza Vaccines Sales by Application (2021-2026) & (US$ Million) Table 54. Global Avian Influenza Vaccines Sales Market Share in Value by Application (2021-2026) Table 55. Global Avian Influenza Vaccines Price by Application (2021-2026) & (USD/K Doses) Table 56. Global Avian Influenza Vaccines Sales by Application (2027-2032) & (M Doses) Table 57. Global Avian Influenza Vaccines Sales Market Share in Volume by Application (2027-2032) Table 58. Global Avian Influenza Vaccines Sales by Application (2027-2032) & (US$ Million) Table 59. Global Avian Influenza Vaccines Sales Market Share in Value by Application (2027-2032) Table 60. Global Avian Influenza Vaccines Price by Application (2027-2032) & (USD/K Doses) Table 61. North America Avian Influenza Vaccines Sales by Application (2021-2026) & (M Doses) Table 62. North America Avian Influenza Vaccines Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Avian Influenza Vaccines Sales by Application (2021-2026) & (M Doses) Table 64. Europe Avian Influenza Vaccines Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Avian Influenza Vaccines Sales by Application (2021-2026) & (M Doses) Table 66. Asia-Pacific Avian Influenza Vaccines Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Avian Influenza Vaccines Sales by Application (2021-2026) & (M Doses) Table 68. Latin America Avian Influenza Vaccines Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Avian Influenza Vaccines Sales by Application (2021-2026) & (M Doses) Table 70. Middle East and Africa Avian Influenza Vaccines Sales by Application (2021-2026) & (US$ Million) Table 71. Merial Company Information Table 72. Merial Business Overview Table 73. Merial Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 74. Merial Avian Influenza Vaccines Product Portfolio Table 75. Merial Recent Development Table 76. QYH Biotech Company Information Table 77. QYH Biotech Business Overview Table 78. QYH Biotech Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 79. QYH Biotech Avian Influenza Vaccines Product Portfolio Table 80. QYH Biotech Recent Development Table 81. DHN Company Information Table 82. DHN Business Overview Table 83. DHN Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 84. DHN Avian Influenza Vaccines Product Portfolio Table 85. DHN Recent Development Table 86. HVRI Company Information Table 87. HVRI Business Overview Table 88. HVRI Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 89. HVRI Avian Influenza Vaccines Product Portfolio Table 90. HVRI Recent Development Table 91. CEVA Company Information Table 92. CEVA Business Overview Table 93. CEVA Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 94. CEVA Avian Influenza Vaccines Product Portfolio Table 95. CEVA Recent Development Table 96. Elanco (Lohmann ) Company Information Table 97. Elanco (Lohmann ) Business Overview Table 98. Elanco (Lohmann ) Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 99. Elanco (Lohmann ) Avian Influenza Vaccines Product Portfolio Table 100. Elanco (Lohmann ) Recent Development Table 101. Yebio Company Information Table 102. Yebio Business Overview Table 103. Yebio Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 104. Yebio Avian Influenza Vaccines Product Portfolio Table 105. Yebio Recent Development Table 106. Zoetis Company Information Table 107. Zoetis Business Overview Table 108. Zoetis Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 109. Zoetis Avian Influenza Vaccines Product Portfolio Table 110. Zoetis Recent Development Table 111. FATRO Company Information Table 112. FATRO Business Overview Table 113. FATRO Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 114. FATRO Avian Influenza Vaccines Product Portfolio Table 115. FATRO Recent Development Table 116. Kyoto Biken Company Information Table 117. Kyoto Biken Business Overview Table 118. Kyoto Biken Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 119. Kyoto Biken Avian Influenza Vaccines Product Portfolio Table 120. Kyoto Biken Recent Development Table 121. CAVAC Company Information Table 122. CAVAC Business Overview Table 123. CAVAC Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 124. CAVAC Avian Influenza Vaccines Product Portfolio Table 125. CAVAC Recent Development Table 126. Ringpu Biology Company Information Table 127. Ringpu Biology Business Overview Table 128. Ringpu Biology Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 129. Ringpu Biology Avian Influenza Vaccines Product Portfolio Table 130. Ringpu Biology Recent Development Table 131. Vaksindo Company Information Table 132. Vaksindo Business Overview Table 133. Vaksindo Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 134. Vaksindo Avian Influenza Vaccines Product Portfolio Table 135. Vaksindo Recent Development Table 136. ChengDu Tecbond Company Information Table 137. ChengDu Tecbond Business Overview Table 138. ChengDu Tecbond Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 139. ChengDu Tecbond Avian Influenza Vaccines Product Portfolio Table 140. ChengDu Tecbond Recent Development Table 141. Sindh Poultry Vaccine Centre Company Information Table 142. Sindh Poultry Vaccine Centre Business Overview Table 143. Sindh Poultry Vaccine Centre Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 144. Sindh Poultry Vaccine Centre Avian Influenza Vaccines Product Portfolio Table 145. Sindh Poultry Vaccine Centre Recent Development Table 146. Merck Animal Health Company Information Table 147. Merck Animal Health Business Overview Table 148. Merck Animal Health Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 149. Merck Animal Health Avian Influenza Vaccines Product Portfolio Table 150. Merck Animal Health Recent Development Table 151. Medion Company Information Table 152. Medion Business Overview Table 153. Medion Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 154. Medion Avian Influenza Vaccines Product Portfolio Table 155. Medion Recent Development Table 156. Avimex Animal Health Company Information Table 157. Avimex Animal Health Business Overview Table 158. Avimex Animal Health Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 159. Avimex Animal Health Avian Influenza Vaccines Product Portfolio Table 160. Avimex Animal Health Recent Development Table 161. JOVAC Company Information Table 162. JOVAC Business Overview Table 163. JOVAC Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 164. JOVAC Avian Influenza Vaccines Product Portfolio Table 165. JOVAC Recent Development Table 166. Bio-Labs Company Information Table 167. Bio-Labs Business Overview Table 168. Bio-Labs Avian Influenza Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 169. Bio-Labs Avian Influenza Vaccines Product Portfolio Table 170. Bio-Labs Recent Development Table 171. North America Avian Influenza Vaccines Market Size Growth Rate (CAGR) by Country (M Doses): 2021 VS 2025 VS 2032 Table 172. North America Avian Influenza Vaccines Sales by Country (2021-2026) & (M Doses) Table 173. North America Avian Influenza Vaccines Sales Market Share by Country (2021-2026) Table 174. North America Avian Influenza Vaccines Sales Forecast by Country (2027-2032) & (M Doses) Table 175. North America Avian Influenza Vaccines Sales Market Share Forecast by Country (2027-2032) Table 176. North America Avian Influenza Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 177. North America Avian Influenza Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 178. North America Avian Influenza Vaccines Market Share by Country (2021-2026) Table 179. North America Avian Influenza Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 180. North America Avian Influenza Vaccines Market Share Forecast by Country (2027-2032) Table 181. Europe Avian Influenza Vaccines Market Size Growth Rate (CAGR) by Country (M Doses): 2021 VS 2025 VS 2032 Table 182. Europe Avian Influenza Vaccines Sales by Country (2021-2026) & (M Doses) Table 183. Europe Avian Influenza Vaccines Sales Market Share by Country (2021-2026) Table 184. Europe Avian Influenza Vaccines Sales Forecast by Country (2027-2032) & (M Doses) Table 185. Europe Avian Influenza Vaccines Sales Market Share Forecast by Country (2027-2032) Table 186. Europe Avian Influenza Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 187. Europe Avian Influenza Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 188. Europe Avian Influenza Vaccines Market Share by Country (2021-2026) Table 189. Europe Avian Influenza Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 190. Europe Avian Influenza Vaccines Market Share Forecast by Country (2027-2032) Table 191. Asia-Pacific Avian Influenza Vaccines Market Size Growth Rate (CAGR) by Country (M Doses): 2021 VS 2025 VS 2032 Table 192. Asia-Pacific Avian Influenza Vaccines Sales by Country (2021-2026) & (M Doses) Table 193. Asia-Pacific Avian Influenza Vaccines Sales Market Share by Country (2021-2026) Table 194. Asia-Pacific Avian Influenza Vaccines Sales Forecast by Country (2027-2032) & (M Doses) Table 195. Asia-Pacific Avian Influenza Vaccines Sales Market Share Forecast by Country (2027-2032) Table 196. Asia-Pacific Avian Influenza Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 197. Asia-Pacific Avian Influenza Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 198. Asia-Pacific Avian Influenza Vaccines Market Share by Country (2021-2026) Table 199. Asia-Pacific Avian Influenza Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 200. Asia-Pacific Avian Influenza Vaccines Market Share Forecast by Country (2027-2032) Table 201. Latin America Avian Influenza Vaccines Market Size Growth Rate (CAGR) by Country (M Doses): 2021 VS 2025 VS 2032 Table 202. Latin America Avian Influenza Vaccines Sales by Country (2021-2026) & (M Doses) Table 203. Latin America Avian Influenza Vaccines Sales Market Share by Country (2021-2026) Table 204. Latin America Avian Influenza Vaccines Sales Forecast by Country (2027-2032) & (M Doses) Table 205. Latin America Avian Influenza Vaccines Sales Market Share Forecast by Country (2027-2032) Table 206. Latin America Avian Influenza Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 207. Latin America Avian Influenza Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 208. Latin America Avian Influenza Vaccines Market Share by Country (2021-2026) Table 209. Latin America Avian Influenza Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 210. Latin America Avian Influenza Vaccines Market Share Forecast by Country (2027-2032) Table 211. Middle East and Africa Avian Influenza Vaccines Market Size Growth Rate (CAGR) by Country (M Doses): 2021 VS 2025 VS 2032 Table 212. Middle East and Africa Avian Influenza Vaccines Sales by Country (2021-2026) & (M Doses) Table 213. Middle East and Africa Avian Influenza Vaccines Sales Market Share by Country (2021-2026) Table 214. Middle East and Africa Avian Influenza Vaccines Sales Forecast by Country (2027-2032) & (M Doses) Table 215. Middle East and Africa Avian Influenza Vaccines Sales Market Share Forecast by Country (2027-2032) Table 216. Middle East and Africa Avian Influenza Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 217. Middle East and Africa Avian Influenza Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 218. Middle East and Africa Avian Influenza Vaccines Market Share by Country (2021-2026) Table 219. Middle East and Africa Avian Influenza Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 220. Middle East and Africa Avian Influenza Vaccines Market Share Forecast by Country (2027-2032) Table 221. Key Raw Materials Table 222. Raw Materials Key Suppliers Table 223. Avian Influenza Vaccines Distributors List Table 224. Avian Influenza Vaccines Customers List Table 225. Research Programs/Design for This Report Table 226. Authors List of This Report Table 227. Secondary Sources Table 228. Primary Sources List of Figures Figure 1. Avian Influenza Vaccines Image Figure 2. Global Avian Influenza Vaccines Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Avian Influenza Vaccines Market Size (2021-2032) & (US$ Million) Figure 4. Global Avian Influenza Vaccines Sales (2021-2032) & (M Doses) Figure 5. H5+H7 Avian Influenza Vaccines Image Figure 6. Global H5+H7 Avian Influenza Vaccines Sales YoY Growth (2021-2032) & (M Doses) Figure 7. H9 Avian Influenza Vaccines Image Figure 8. Global H9 Avian Influenza Vaccines Sales YoY Growth (2021-2032) & (M Doses) Figure 9. Global Avian Influenza Vaccines Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Avian Influenza Vaccines Market Share by Type 2025 VS 2032 Figure 11. North America Avian Influenza Vaccines Sales Market Share in Volume by Type in 2025 Figure 12. North America Avian Influenza Vaccines Sales Market Share in Value by Type in 2025 Figure 13. Europe Avian Influenza Vaccines Sales Market Share in Volume by Type in 2025 Figure 14. Europe Avian Influenza Vaccines Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Avian Influenza Vaccines Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Avian Influenza Vaccines Sales Market Share in Value by Type in 2025 Figure 17. Latin America Avian Influenza Vaccines Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Avian Influenza Vaccines Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Avian Influenza Vaccines Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Avian Influenza Vaccines Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Avian Influenza Vaccines Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Chicken Avian Influenza Vaccines Image Figure 24. Global Chicken Avian Influenza Vaccines Sales YoY Growth (2021-2032) & (M Doses) Figure 25. Duck & Goose Avian Influenza Vaccines Image Figure 26. Global Duck & Goose Avian Influenza Vaccines Sales YoY Growth (2021-2032) & (M Doses) Figure 27. Other Image Figure 28. Global Other Sales YoY Growth (2021-2032) & (M Doses) Figure 29. Global Avian Influenza Vaccines Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Avian Influenza Vaccines Market Share by Application 2025 VS 2032 Figure 31. North America Avian Influenza Vaccines Sales Market Share in Volume by Application in 2025 Figure 32. North America Avian Influenza Vaccines Sales Market Share in Value by Application in 2025 Figure 33. Europe Avian Influenza Vaccines Sales Market Share in Volume by Application in 2025 Figure 34. Europe Avian Influenza Vaccines Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Avian Influenza Vaccines Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Avian Influenza Vaccines Sales Market Share in Value by Application in 2025 Figure 37. Latin America Avian Influenza Vaccines Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Avian Influenza Vaccines Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Avian Influenza Vaccines Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Avian Influenza Vaccines Sales Market Share in Value by Application in 2025 Figure 41. North America Avian Influenza Vaccines Sales by Country: 2021 VS 2025 VS 2032 (M Doses) Figure 42. North America Avian Influenza Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Avian Influenza Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Avian Influenza Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Avian Influenza Vaccines Sales by Country: 2021 VS 2025 VS 2032 (M Doses) Figure 46. Europe Avian Influenza Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Avian Influenza Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Avian Influenza Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Avian Influenza Vaccines Sales by Country: 2021 VS 2025 VS 2032 (M Doses) Figure 50. Asia-Pacific Avian Influenza Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Avian Influenza Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Avian Influenza Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Avian Influenza Vaccines Sales by Country: 2021 VS 2025 VS 2032 (M Doses) Figure 54. Latin America Avian Influenza Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Avian Influenza Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Avian Influenza Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Avian Influenza Vaccines Sales by Country: 2021 VS 2025 VS 2032 (M Doses) Figure 58. Middle East and Africa Avian Influenza Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Avian Influenza Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Avian Influenza Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Avian Influenza Vaccines Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Avian Influenza Vaccines Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • H5+H7 Avian Influenza Vaccines
  • H9 Avian Influenza Vaccines
Applications
  • Chicken Avian Influenza Vaccines
  • Duck & Goose Avian Influenza Vaccines
  • Other
Companies covered
  • Merial
  • QYH Biotech
  • DHN
  • HVRI
  • CEVA
  • Elanco (Lohmann )
  • Yebio
  • Zoetis
  • FATRO
  • Kyoto Biken
  • CAVAC
  • Ringpu Biology
  • Vaksindo
  • ChengDu Tecbond
  • Sindh Poultry Vaccine Centre
  • Merck Animal Health
  • Medion
  • Avimex Animal Health
  • JOVAC
  • Bio-Labs

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Avian Influenza Vaccines Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Avian Influenza Vaccines Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Avian Influenza Vaccines Market by Type
  6. 1.3.1 H5+H7 Avian Influenza Vaccines
  7. 1.3.2 H9 Avian Influenza Vaccines
  8. 1.4 Global Avian Influenza Vaccines Market Size by Type
  9. 1.4.1 Global Avian Influenza Vaccines Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Avian Influenza Vaccines Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Avian Influenza Vaccines Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Avian Influenza Vaccines Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Avian Influenza Vaccines Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Avian Influenza Vaccines Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Avian Influenza Vaccines Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Avian Influenza Vaccines Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Avian Influenza Vaccines Industry Trends
  2. 2.2 Avian Influenza Vaccines Industry Drivers
  3. 2.3 Avian Influenza Vaccines Industry Opportunities and Challenges
  4. 2.4 Avian Influenza Vaccines Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Avian Influenza Vaccines Revenue (2021-2026)
  2. 3.2 Global Top Players by Avian Influenza Vaccines Sales (2021-2026)
  3. 3.3 Global Top Players by Avian Influenza Vaccines Price (2021-2026)
  4. 3.4 Global Avian Influenza Vaccines Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Avian Influenza Vaccines Major Company Production Sites & Headquarters
  6. 3.6 Global Avian Influenza Vaccines Company, Product Type & Application
  7. 3.7 Global Avian Influenza Vaccines Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Avian Influenza Vaccines Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Avian Influenza Vaccines Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Avian Influenza Vaccines Tier 1, Tier 2, and Tier 3
4 Avian Influenza Vaccines Regional Status and Outlook
  1. 4.1 Global Avian Influenza Vaccines Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Avian Influenza Vaccines Historic Market Size by Region
  3. 4.2.1 Global Avian Influenza Vaccines Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Avian Influenza Vaccines Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Avian Influenza Vaccines Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Avian Influenza Vaccines Forecasted Market Size by Region
  7. 4.3.1 Global Avian Influenza Vaccines Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Avian Influenza Vaccines Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Avian Influenza Vaccines Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Avian Influenza Vaccines by Application
  1. 5.1 Avian Influenza Vaccines Market by Application
  2. 5.1.1 Chicken Avian Influenza Vaccines
  3. 5.1.2 Duck & Goose Avian Influenza Vaccines
  4. 5.1.3 Other
  5. 5.2 Global Avian Influenza Vaccines Market Size by Application
  6. 5.2.1 Global Avian Influenza Vaccines Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Avian Influenza Vaccines Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Avian Influenza Vaccines Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Avian Influenza Vaccines Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Avian Influenza Vaccines Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Avian Influenza Vaccines Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Avian Influenza Vaccines Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Avian Influenza Vaccines Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Merial
  2. 6.1.1 Merial Company Information
  3. 6.1.2 Merial Business Overview
  4. 6.1.3 Merial Avian Influenza Vaccines Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Merial Avian Influenza Vaccines Product Portfolio
  6. 6.1.5 Merial Recent Developments
  7. 6.2 QYH Biotech
  8. 6.2.1 QYH Biotech Company Information
  9. 6.2.2 QYH Biotech Business Overview
  10. 6.2.3 QYH Biotech Avian Influenza Vaccines Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 QYH Biotech Avian Influenza Vaccines Product Portfolio
  12. 6.2.5 QYH Biotech Recent Developments
  13. 6.3 DHN
  14. 6.3.1 DHN Company Information
  15. 6.3.2 DHN Business Overview
  16. 6.3.3 DHN Avian Influenza Vaccines Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 DHN Avian Influenza Vaccines Product Portfolio
  18. 6.3.5 DHN Recent Developments
  19. 6.4 HVRI
  20. 6.4.1 HVRI Company Information
  21. 6.4.2 HVRI Business Overview
  22. 6.4.3 HVRI Avian Influenza Vaccines Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 HVRI Avian Influenza Vaccines Product Portfolio
  24. 6.4.5 HVRI Recent Developments
  25. 6.5 CEVA
  26. 6.5.1 CEVA Company Information
  27. 6.5.2 CEVA Business Overview
  28. 6.5.3 CEVA Avian Influenza Vaccines Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 CEVA Avian Influenza Vaccines Product Portfolio
  30. 6.5.5 CEVA Recent Developments
  31. 6.6 Elanco (Lohmann )
  32. 6.6.1 Elanco (Lohmann ) Company Information
  33. 6.6.2 Elanco (Lohmann ) Business Overview
  34. 6.6.3 Elanco (Lohmann ) Avian Influenza Vaccines Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Elanco (Lohmann ) Avian Influenza Vaccines Product Portfolio
  36. 6.6.5 Elanco (Lohmann ) Recent Developments
  37. 6.7 Yebio
  38. 6.7.1 Yebio Company Information
  39. 6.7.2 Yebio Business Overview
  40. 6.7.3 Yebio Avian Influenza Vaccines Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Yebio Avian Influenza Vaccines Product Portfolio
  42. 6.7.5 Yebio Recent Developments
  43. 6.8 Zoetis
  44. 6.8.1 Zoetis Company Information
  45. 6.8.2 Zoetis Business Overview
  46. 6.8.3 Zoetis Avian Influenza Vaccines Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Zoetis Avian Influenza Vaccines Product Portfolio
  48. 6.8.5 Zoetis Recent Developments
  49. 6.9 FATRO
  50. 6.9.1 FATRO Company Information
  51. 6.9.2 FATRO Business Overview
  52. 6.9.3 FATRO Avian Influenza Vaccines Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 FATRO Avian Influenza Vaccines Product Portfolio
  54. 6.9.5 FATRO Recent Developments
  55. 6.10 Kyoto Biken
  56. 6.10.1 Kyoto Biken Company Information
  57. 6.10.2 Kyoto Biken Business Overview
  58. 6.10.3 Kyoto Biken Avian Influenza Vaccines Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Kyoto Biken Avian Influenza Vaccines Product Portfolio
  60. 6.10.5 Kyoto Biken Recent Developments
  61. 6.11 CAVAC
  62. 6.11.1 CAVAC Company Information
  63. 6.11.2 CAVAC Business Overview
  64. 6.11.3 CAVAC Avian Influenza Vaccines Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 CAVAC Avian Influenza Vaccines Product Portfolio
  66. 6.11.5 CAVAC Recent Developments
  67. 6.12 Ringpu Biology
  68. 6.12.1 Ringpu Biology Company Information
  69. 6.12.2 Ringpu Biology Business Overview
  70. 6.12.3 Ringpu Biology Avian Influenza Vaccines Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Ringpu Biology Avian Influenza Vaccines Product Portfolio
  72. 6.12.5 Ringpu Biology Recent Developments
  73. 6.13 Vaksindo
  74. 6.13.1 Vaksindo Company Information
  75. 6.13.2 Vaksindo Business Overview
  76. 6.13.3 Vaksindo Avian Influenza Vaccines Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Vaksindo Avian Influenza Vaccines Product Portfolio
  78. 6.13.5 Vaksindo Recent Developments
  79. 6.14 ChengDu Tecbond
  80. 6.14.1 ChengDu Tecbond Company Information
  81. 6.14.2 ChengDu Tecbond Business Overview
  82. 6.14.3 ChengDu Tecbond Avian Influenza Vaccines Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 ChengDu Tecbond Avian Influenza Vaccines Product Portfolio
  84. 6.14.5 ChengDu Tecbond Recent Developments
  85. 6.15 Sindh Poultry Vaccine Centre
  86. 6.15.1 Sindh Poultry Vaccine Centre Company Information
  87. 6.15.2 Sindh Poultry Vaccine Centre Business Overview
  88. 6.15.3 Sindh Poultry Vaccine Centre Avian Influenza Vaccines Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Sindh Poultry Vaccine Centre Avian Influenza Vaccines Product Portfolio
  90. 6.15.5 Sindh Poultry Vaccine Centre Recent Developments
  91. 6.16 Merck Animal Health
  92. 6.16.1 Merck Animal Health Company Information
  93. 6.16.2 Merck Animal Health Business Overview
  94. 6.16.3 Merck Animal Health Avian Influenza Vaccines Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Merck Animal Health Avian Influenza Vaccines Product Portfolio
  96. 6.16.5 Merck Animal Health Recent Developments
  97. 6.17 Medion
  98. 6.17.1 Medion Company Information
  99. 6.17.2 Medion Business Overview
  100. 6.17.3 Medion Avian Influenza Vaccines Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 Medion Avian Influenza Vaccines Product Portfolio
  102. 6.17.5 Medion Recent Developments
  103. 6.18 Avimex Animal Health
  104. 6.18.1 Avimex Animal Health Company Information
  105. 6.18.2 Avimex Animal Health Business Overview
  106. 6.18.3 Avimex Animal Health Avian Influenza Vaccines Sales, Revenue and Gross Margin (2021-2026)
  107. 6.18.4 Avimex Animal Health Avian Influenza Vaccines Product Portfolio
  108. 6.18.5 Avimex Animal Health Recent Developments
  109. 6.19 JOVAC
  110. 6.19.1 JOVAC Company Information
  111. 6.19.2 JOVAC Business Overview
  112. 6.19.3 JOVAC Avian Influenza Vaccines Sales, Revenue and Gross Margin (2021-2026)
  113. 6.19.4 JOVAC Avian Influenza Vaccines Product Portfolio
  114. 6.19.5 JOVAC Recent Developments
  115. 6.20 Bio-Labs
  116. 6.20.1 Bio-Labs Company Information
  117. 6.20.2 Bio-Labs Business Overview
  118. 6.20.3 Bio-Labs Avian Influenza Vaccines Sales, Revenue and Gross Margin (2021-2026)
  119. 6.20.4 Bio-Labs Avian Influenza Vaccines Product Portfolio
  120. 6.20.5 Bio-Labs Recent Developments
7 North America by Country
  1. 7.1 North America Avian Influenza Vaccines Sales by Country
  2. 7.1.1 North America Avian Influenza Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Avian Influenza Vaccines Sales by Country (2021-2026)
  4. 7.1.3 North America Avian Influenza Vaccines Sales Forecast by Country (2027-2032)
  5. 7.2 North America Avian Influenza Vaccines Market Size by Country
  6. 7.2.1 North America Avian Influenza Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Avian Influenza Vaccines Market Size by Country (2021-2026)
  8. 7.2.3 North America Avian Influenza Vaccines Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Avian Influenza Vaccines Sales by Country
  2. 8.1.1 Europe Avian Influenza Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Avian Influenza Vaccines Sales by Country (2021-2026)
  4. 8.1.3 Europe Avian Influenza Vaccines Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Avian Influenza Vaccines Market Size by Country
  6. 8.2.1 Europe Avian Influenza Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Avian Influenza Vaccines Market Size by Country (2021-2026)
  8. 8.2.3 Europe Avian Influenza Vaccines Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Avian Influenza Vaccines Sales by Country
  2. 9.1.1 Asia-Pacific Avian Influenza Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Avian Influenza Vaccines Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Avian Influenza Vaccines Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Avian Influenza Vaccines Market Size by Country
  6. 9.2.1 Asia-Pacific Avian Influenza Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Avian Influenza Vaccines Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Avian Influenza Vaccines Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Avian Influenza Vaccines Sales by Country
  2. 10.1.1 South America Avian Influenza Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Avian Influenza Vaccines Sales by Country (2021-2026)
  4. 10.1.3 South America Avian Influenza Vaccines Sales Forecast by Country (2027-2032)
  5. 10.2 South America Avian Influenza Vaccines Market Size by Country
  6. 10.2.1 South America Avian Influenza Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Avian Influenza Vaccines Market Size by Country (2021-2026)
  8. 10.2.3 South America Avian Influenza Vaccines Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Avian Influenza Vaccines Sales by Country
  2. 11.1.1 Middle East and Africa Avian Influenza Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Avian Influenza Vaccines Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Avian Influenza Vaccines Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Avian Influenza Vaccines Market Size by Country
  6. 11.2.1 Middle East and Africa Avian Influenza Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Avian Influenza Vaccines Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Avian Influenza Vaccines Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Avian Influenza Vaccines Value Chain Analysis
  2. 12.1.1 Avian Influenza Vaccines Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Avian Influenza Vaccines Production Mode & Process
  7. 12.2 Avian Influenza Vaccines Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Avian Influenza Vaccines Distributors
  10. 12.2.3 Avian Influenza Vaccines Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst